Back
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
55
GVUS
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF
Last Price:
$53.94
Seasonality Move:
0.63%
Sell
17
NONOF
Novo Nordisk A/S
Last Price:
$35.59
Seasonality Move:
4.8%
Buy
55
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF (GVUS)
is a Buy
Is Goldman Sachs MarketBeta Russell 1000 Value Eq ETF a Buy, Sell or Hold?
-
The current Goldman Sachs MarketBeta Russell 1000 Value Eq ETF [GVUS] share price is $55.34. The Score for GVUS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
GVUS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
17
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $35.59. The Score for NONOF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
GVUS Stock Price Chart
What is Goldman Sachs MarketBeta Russell 1000 Value Eq ETF's stock price today?
-
The Goldman Sachs MarketBeta Russell 1000 Value Eq ETF share price today is $55.34Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GVUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $35.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
GVUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.48 | Sell |
| Relative Strength Index (14 RSI): | 48.36 | Sell |
| Chaikin Money Flow: | 3136 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.56 - 56.7) | Sell |
| Bollinger Bands (100): | (53.6 - 56.9) | Buy |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.13 | Sell |
| Relative Strength Index (14 RSI): | 34 | Sell |
| Chaikin Money Flow: | -84014 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.94 - 38.44) | Sell |
| Bollinger Bands (100): | (39.64 - 55.38) | Sell |
GVUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.75 | Buy |
| 20-day SMA: | 55.19 | Buy |
| 50-day SMA: | 56.39 | Sell |
| 200-day SMA: | 53.28 | Buy |
| 8-day EMA: | 54.9 | Buy |
| 20-day EMA: | 55.3 | Buy |
| 50-day EMA: | 55.69 | Sell |
| 200-day EMA: | 53.55 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.83 | Sell |
| 20-day SMA: | 37 | Sell |
| 50-day SMA: | 44.15 | Sell |
| 200-day SMA: | 53.01 | Sell |
| 8-day EMA: | 35.83 | Sell |
| 20-day EMA: | 37.34 | Sell |
| 50-day EMA: | 41.96 | Sell |
| 200-day EMA: | 54.32 | Sell |
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Earnings Growth & GVUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||